Skip to content
StockMarketAgent
← Back to latest report
ZTS · Archive

ZTS · Monthly research archive

Every month we publish a fresh rating. Read prior months' commentary, ratings, and price trend at a glance.

2026-05Zdecydowanie kupuj

ZTS May 2026 · strong-buy

Zoetis is a dominant, mature compounder in the animal health space, benefiting from high switching costs, robust brand loyalty, and significant scale economies. With consistent mid-single-digit revenue growth and high operating margins (~37%), it generates strong and predictable free cash flow.

$76.94